乙型肝炎病毒(HBV)上调肝细胞TRAIL-R3表达从而同时逃逸细胞凋亡和TRAIL对HBV复制的抑制
研究利用HBV感染的人肝细胞移植小鼠肝脏进行基因表达分析,发现TRAIL-R3显著上调,并经体外和体内HBV复制模型验证,该上调由HBx通过激活NF-κB信号调控TRAIL-R3启动子区域所介导。TRAIL既诱导细胞凋亡又抑制HBV复制,而TRAIL-R3上调可同时抑制这两种TRAIL依赖的作用,提示HBV通过上调TRAIL-R3逃逸宿主免疫而持续存在。
要点
- HBV感染人肝细胞移植小鼠肝脏中TRAIL-R3显著上调,经体外和体内模型验证。
- TRAIL-R3上调由HBx通过激活NF-κB信号调控启动子-969至-479核苷酸区域介导。
- TRAIL-R3上调可同时抑制TRAIL诱导的肝细胞凋亡和TRAIL对HBV复制的抑制。
核心结论
- 结果提示HBV通过上调TRAIL-R3逃逸宿主免疫而持续存在的机制。
- 开发抑制该逃逸系统的新型药物可能有助于从人肝细胞中完全清除HBV。
研究设计与样本
- 利用HBV感染的人肝细胞移植小鼠肝脏进行基因表达分析(cDNA微阵列和下一代测序)。
- 使用人肝细胞移植小鼠和HepG2细胞系分析TRAIL-R3上调在HBV感染中的意义。
- 通过体外和体内HBV复制模型验证HBV感染对TRAIL-R3的诱导。
主要发现
- HBV感染人肝细胞移植小鼠肝脏中TRAIL-R3显著上调。
- TRAIL-R3诱导经体外和体内HBV复制模型验证,且可被抗病毒核苷(酸)类似物治疗抑制。
- TRAIL-R3转录受转录起始位点上游-969至-479核苷酸的TRAIL-R3启动子调控,并由HBx通过激活NF-κB信号介导。
- TRAIL不仅诱导细胞凋亡,还抑制HBV复制。
- TRAIL-R3上调可抑制HBV感染肝细胞中TRAIL依赖的凋亡以及TRAIL介导的HBV复制抑制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis B virus (HBV) evades host immunity by regulating intracellular signals. To clarify this immune tolerance mechanism, we performed gene expression analysis using HBV-infected humanized mouse livers. METHODS: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 3 (TRAIL-R3) was significantly upregulated in livers of HBV-infected human hepatocyte transplanted mice by cDNA microarray and next-generation sequencing. We analyzed the significance of TRAIL-R3 upregulation in HBV infection using human hepatocyte transplanted mice and HepG2 cell lines. RESULTS: TRAIL-R3 induction by HBV infection was verified by in vitro and in vivo HBV replication models, and induction was inhibited by antiviral nucleot(s)ide analogue treatment. TRAIL-R3 transcription was regulated by the TRAIL-R3 promoter at -969 to -479 nucleotides upstream from the transcription start site, and by hepatitis B x (HBx) via activation of nuclear factor-κB (NF-κB) signal. TRAIL not only induced cell apoptosis but also inhibited HBV replication. TRAIL-R3 upregulation could inhibit both TRAIL-dependent apoptosis in HBV-infected hepatocytes and TRAIL-mediated suppression of HBV replication. CONCLUSIONS: These results suggest a mechanism by which HBV persists by escaping host immunity through upregulation of TRAIL-R3. Development of novel drugs to inhibit this escape system might lead to complete HBV elimination from human hepatocytes.
引用
- Suehiro Y, Tsuge M, Kurihara M, et al. Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL. J Infect Dis. 2023. PMID: 35226068. doi:10.1093/infdis/jiac044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。